You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 7,417,022


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,417,022
Title:Compounds and compositions for delivering active agents
Abstract: Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
Inventor(s): Leone-Bay; Andrea (Ridgefield, CT), Milstein; Sam J. (Larchmont, NY), Sarubbi; Donald J. (Bolton, MA), Leipold; Harry (Elmsford, NY)
Assignee: MHR Institutional Partners IIA LP (New York, NY)
Application Number:11/104,173
Patent Claims:1. A pharmacological composition comprising: (A) parathyroid hormone; and (B) at least one carrier compound having the formula 2-HO--Ar--CONR.sup.8--R.sup.7--COOH wherein Ar is a substituted or unsubstituted phenyl or naphthyl; R.sup.7 is selected from the group consisting of C.sub.4 to C.sub.20 alkyl, C.sub.4 to C.sub.20 alkenyl, phenyl, naphthyl, (C.sub.1 to C.sub.10 alkyl) phenyl, (C.sub.1 to C.sub.10 alkenyl)phenyl, (C.sub.1 to C.sub.10 alkyl) naphthyl, (C.sub.1 to C.sub.10 alkenyl)naphthyl, phenyl (C.sub.1 to C.sub.10 alkyl), phenyl (C.sub.1 to C.sub.10 alkenyl), naphthyl (C.sub.1 to C.sub.10 alkyl), and naphthyl (C.sub.1 to C.sub.10 alkenyl); R.sup.8 is selected from the group consisting of hydrogen, C.sub.1 to C.sub.4 alkyl, C.sub.1 to C.sub.4 alkenyl, hydroxy, and C.sub.1 to C.sub.4 alkoxy; R.sup.7 is optionally substituted with C.sub.1 to C.sub.4 alkyl, C.sub.1 to C.sub.4 alkenyl, C.sub.1 to C.sub.4 alkoxy, --OH, --SH and --CO.sub.2R.sup.9 any combination thereof; R.sup.9 is hydrogen, C.sub.1 to C.sub.4 alkyl or C.sub.1 to C.sub.4 alkenyl; R.sup.7 is optionally interrupted by oxygen, nitrogen, sulfur or any combination thereof; with the proviso that the compounds are not substituted with an amino group in the position alpha to the acid group; or salts thereof.

2. The composition according to claim 1, wherein R.sup.7 is C.sub.4 to C.sub.20 alkyl.

3. The composition according to claim 1, wherein R.sup.7 is C.sub.5 to C.sub.20 alkyl.

4. The composition according to claim 1 wherein the carrier has the formula ##STR00067## or a salt thereof.

5. The composition according to claim 1 wherein said carrier is a compound selected from the group consisting of ##STR00068## ##STR00069## or salts thereof.

6. The composition according to claim 1 wherein the carrier is a compound selected from the group consisting of TABLE-US-00009 A ##STR00070## Compound n m X LII 1 0 2-OH LIII 3 0 2,6-dihydroxy LIV 2 0 2-OH LVI 2 0 2,6-dihydroxy

or salts thereof.

7. The composition according to claim 1 wherein the carrier is a compound selected from the group consisting of TABLE-US-00010 G ##STR00071## Compound n m X CXI 6 0 2-OH CXIX 9 0 2-OH

or salts thereof.

8. The composition according to claim 1, wherein said carrier has the formula ##STR00072## or a salt thereof.

9. The composition according to claim 1 wherein the carrier has the formula ##STR00073## or a salt thereof.

10. A dosage unit form comprising (A) a pharmacological composition according to claim 1; and (B) (a) an excipient, (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof.

11. A dosage unit form according to claim 10, comprising a tablet, a capsule, or a liquid.

12. A dosage unit form according to claim 11, wherein said dosing vehicle is selected from the group consisting of water, 1,2-propane diol, ethanol or any combination thereof.

13. A method for administering parathyroid hormone to a mammal in need of said agent, said method comprising administering orally to said mammal a composition as defined in claim 1.

14. A method for preparing a pharmacological composition, said method comprising mixing: (A) parathyroid hormone; (B) at least one carrier compound according to claim 1; and (C) optionally a dosing vehicle.

15. A method for administering parathyroid hormone to an animal in need thereof, said method comprising administering orally to said mammal a composition as defined in claim 1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.